Advicenne Publishes its 2019 Half-Year Financial Report
September 27, 2019
Advicenne (Euronext: ADVIC – FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney disease, today announces the publication of its 2019 half-year financial report.